Why the study?
Does meal intake reduce plasma proANP and proBNP concentrations in healthy young individuals?
Does meal intake reduce plasma proANP and proBNP concentrations in healthy young individuals?
Meal intake significantly decreases plasma proANP concentrations, suggesting that clinical measurements of proANP for heart failure diagnosis should be performed in the fasting state to avoid false negatives.
Answers are grounded in this paper and cite their sources.
Recent meal intake may lower proANP and risk false-negative HF readings; leaves open fasting standardization in broader cohorts.
To the Editor: Cardiac natriuretic peptides and their molecular precursor fragments are sensitive plasma markers of congestive heart failure and left ventricular dysfunction. Most studies on their value as markers in cardiac diseases have also addressed the effects of aging and sex, in which increasing age and female sex are associated with higher concentrations per se and thus are recommended to be included in establishing reference intervals. Biological variation has also been associated with the circadian pattern of cardiac natriuretic peptide mRNA contents in mice and the concomitant plasma concentrations in humans. New findings have demonstrated that natriuretic peptides and their receptors are involved in fat and muscle metabolism (1). These data, combined with the observation that obese people display lower plasma concentrations than individuals of normal weight, suggest that cardiac natriuretic peptides are also involved, for instance, in the metabolic syndrome and perhaps even in diabetes. No study thus far has tested whether plasma concentrations of pro–atrial-type natriuretic peptide (proANP)1 and pro–brain-type natriuretic peptide (BNP) may be affected by meal intake, a standard stimulus for the gastrointestinal output of hormones involved in glucose metabolism. Therefore, in this study the 3-h effect of meal intake in healthy young individuals was tested. Six healthy young individuals between 20 and 30 years of age (2 men and 4 women) were included. None of the participants reported having any known disease, and all were free of medication. All individuals gave informed consent to participate, and the study was performed according to the Helsinki Declaration. The participants fasted overnight and met at 0800 for the test. An intravenous catheter was inserted into the antecubital vein for blood sampling. The meal consisted of 250 g roast beef, 300 g oven-baked potatoes in cream sauce, 1 bread roll, and 250 mL orange juice (1500 calories total). Water was administered ad libitum. Ten milliliters of blood was collected into EDTA-containing tubes every 10–15 min, kept on ice, and then immediately centrifuged (2500g) for 10 min. The plasma was then stored at −80 °C until analysis. Plasma proANP was measured with an in-house assay, a so-called processing-independent assay (2). Assay performance and its correlation to midregional proANP measurement have previously been published (3). That comparison established a median proANP concentration for healthy individuals (230 pmol/L; upper 97% percentile, 468 pmol/L). For plasma proBNP, we used another processing-independent assay developed for human proBNP (4). The performance of the assay and its correlation with other proBNP methods have been published (5). The results of proANP measurements are shown in Fig. 1. The fasting mean plasma concentration was 176 pmol/L (95% CI, 134–218 pmol/L; n = 6). A decrease in plasma proANP was observed at 60 min and in hour 3 of the experiment. The statistical significance of these changes were tested with one-way ANOVA, followed by the Newman-Keuls multiple-comparison test (P = 0.0018). Although not statistically significant, a minor decrease was also noted 10 min after the start of the meal. In contrast, no changes were seen in plasma proBNP over the whole course of the 180-min experiment (data not shown). **P < 0.01, for times of significant changes in proANP concentration compared with the concentrations at −10 min and 0 min. Similarly, *P < 0.05. The present study revealed that plasma proANP concentrations decrease dramatically in healthy young individuals after meal intake. In contrast, no such effect was observed for proBNP in plasma. To the best of the author's knowledge, this decrease in proANP after food intake has not been reported previously, but it may have direct clinical implications. No rules for fasting before blood sampling for proANP analysis have been recommended thus far. In a worst-case scenario, the results of the present study imply that an increase in proANP as a marker for heart failure could be missed with a nonfasting sample. If the clinical presentation is unclear, such an occurrence could have dire consequences for the patient with values that are otherwise in the diagnostically “gray zone.” For now, the recommendation is that proANP measurements be made on fasting patients. Future studies must also examine the effects of meal intake on the active hormones (ANP and BNP), for which their profiles with respect to food intake are completely unknown. Finally, investigations for mechanistic insights into this phenomenon should address the possible relationship between insulin and natriuretic peptide secretion to explain the current finding and perhaps the reportedly low plasma proANP and proBNP concentrations in obese persons. In conclusion, plasma proANP concentrations, but not proBNP concentrations, are affected by meal intake, with a decrease of 50% after 2 h. This observation needs to be confirmed in clinical studies of proANP. If the results are confirmed, the findings may provide new biological insight into insulin-resistant persons or patients with diabetes. pro–atrial-type natriuretic peptide pro–brain-type natriuretic peptide. The expert technical assistance of R. Krøncke is gratefully acknowledged.
No takes yet. Share an insight, caveat, or question.
Jens P. Goetze (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: